The JDRF funded human clinical trial showing continuous glucose monitors (CGM) can improve diabetes control was recently cited by ABC as one of the top 10 medical breakthroughs of 2008. ABCNews.com chose 10 developments as most important scientific breakthrough both by medical practitioners and by readers, including advances in Alzheimer’s research and an early blood test for Down syndrome.
This was the first major, multi-center trial documenting the benefits of CGM for Type 1 diabetes control. The JDRF study was a randomized, controlled trial involving 322 patients spanning the age range of 8 to 72 years at 10 sites, which included academic, community, and managed care-based practices nationwide.
We’re thrilled to see diabetes in the media spotlight and are excited about what it will help 2009 bring for those of us with diabetes. At the very least, we hope to help heal the FDA (www.healthefda.com) and maybe see more people covered by insurance for CGM.